Effect of KETOgenic Diet on Metabolism, Inflammation, Nutrition Deficiencies and OXidative Stress in Women With Overweight
Launched by POLISH ACADEMY OF SCIENCES · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Active, not recruiting
Keywords
ClinConnect Summary
In recent times, the prevalence of obesity increases, reaching an epidemic scale. A new factor supporting a weight gain is a current coronaviros (COVID-19) pandemic, associated with reduced physical activity, high stress and overeating, which resulted in 2-5 kg weight gain in 20 % of the American population within a few months 1. Elevated body weight is a risk factor in developing several diseases such as diabetes, hypertension and cancer. Therefore, obesity management solutions, such as diet therapy, are needed. The critical issue is to choose the most appropriate diet to obtain an efficie...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women
- • age 18-45
- • overweight (BMI 27 - 35)
- • motivation to lose weight and participate in the nutritional intervention trial
- Exclusion Criteria:
- • overweight/obesity secondary to genetic syndromes
- • endocrine diseases, acute systemic disease, autoimmune disorders
- • pregnancy
- • breastfeeding
- • type 1 and 2 diabetes
- • any other chronic diseases requiring pharmacotherapy (including topical steroids in allergy disorders
- • supplement or medication use influencing appetite, weight or metabolism)
- • participation in other clinical trials
- • severe obesity (BMI \> 35)
- • \> 3 kg weight loss 12 weeks before the initial test day
- • extreme changes in exercise intensity 4 weeks prior
- • any diagnosed psychiatric disorders
Trial Officials
Natalia Drabińska, PhD
Principal Investigator
Institute of Animal Reproduction and Food Reseach, Polish Academy of Sciences in Olsztyn
Jerzy Romaszko, MD, PhD
Principal Investigator
Deaprtment of Family Medicine and Infectious Diseases, Faculty of Medical Sciences, University of Warmia and Mazury
About Polish Academy Of Sciences
The Polish Academy of Sciences, a prestigious national research institution, is dedicated to advancing scientific knowledge and innovation in Poland and beyond. With a focus on interdisciplinary collaboration, the Academy supports a wide range of research initiatives, including clinical trials aimed at improving healthcare outcomes. Its commitment to rigorous scientific methodology and ethical standards ensures the integrity and reliability of its studies. By fostering partnerships with universities, healthcare providers, and industry stakeholders, the Polish Academy of Sciences plays a pivotal role in translating research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Olsztyn, , Poland
Olsztyn, , Poland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials